WEBINAR: Lecture series Infection & Immunity: "SARS-CoV-2 caused Multisystem Inflammatory Syndrome in Children (MIS-C)"- Prof Dusan Bogunovic

On February 25th, Prof Simone Niclou, Director of the LIH Department of Oncology (DONC) and group leader of the NORLUX Neuro-Oncology Laboratory, was awarded a EUR 850,000 check by the Fondation Cancer and the Luxembourg National Research Fund (FNR) in support of the GLASS-LUX study.

On February 25th, three LIH group leaders from the Department of Oncology (DONC) were awarded a symbolic check by the Fondation Cancer and the Luxembourg National Research Fund (FNR) in support of their cancer research projects.

45th GRELL ANNUAL CONFERENCE - From 12th to 14th MAY 2021- The National Cancer Registry of the Grand Duchy of Luxembourg and the LIH have the great pleasure to invite you to attend the virtual 45th GRELL Annual Conference on cancer epidemiology and cancer research of one of the oldest cancer epidemiology associations worldwide (www.grell-network.org)

WEBINAR: Lecture series Cancer Research: "Translating the Science of Gliomas: Current Concepts & Future Challenges" - Prof Colin Watts

High blood pressure (HBP) or hypertension is often called the ‘‘silent killer’’, due to the lack of obvious symptoms indicating its presence. It is therefore important to be able to self-monitor one’s blood pressure and understand how to interpret the measurements. To this end, the Cardiovascular Research Unit (CVRU) of the LIH Department of Population Health (DoPH) recently published an informative brochure to help shed light into cardiovascular health.

The Tumor Immunotherapy and Microenvironment (TIME) research group of the LIH Department of Oncology (DONC) teamed up with Swedish Pharma company Sprint Bioscience to investigate the therapeutic benefit of small molecules inhibiting key pathways in cancer cells. The aim is to potentiate the effectiveness of immunotherapy and providing innovative and translational approaches to treating several cancers.

Researchers from the Department of Infection and Immunity of the Luxembourg Institute of Health (LIH) brought forward the potential of high doses of a specific adjuvant molecule, namely CpG oligonucleotide, in successfully modulating the immune system’s allergic response to the main cat allergen Fel d 1, thereby inducing a tolerance-promoting reaction and reverting the main hallmarks of cat allergy. The researchers analysed the molecular mechanisms underlying this tolerance and proposed a pre-clinical allergen-specific immunotherapy approach to improve the treatment and control of this common type of allergy. The full study results were published very recently in the renowned international journal “Allergy”, the official journal of the European Academy of Allergy and Clinical Immunology (EAACI) and one of the top two journals worldwide in the allergy field.

On January 27th, the Global Observatory for Physical Activity (GoPA!) released its second round of physical activity country profiles, presenting detailed information on physical activity research, policy and surveillance in 162 countries across the world. The Physical Activity, Sport and Health research group of the LIH Department of Population Health (DoPH) was the point of contact for the 2020 Country Card for Luxembourg, contributing with the data and information generated through past population studies in order to give an overview of the country’s performance in this domain.